ENTO

Entero Therapeutics Appoints Richard Paolone as CEO

时间：2025-02-15 05:00:03 市场： 美股 综合

关联： ENTO

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members

时间：2025-02-08 04:22:22 市场： 美股 综合

关联： ENTO

Entero Therapeutics : Notice Informed Immunogenx That One or More Events of Default Under Credit Agreement Were Existing and Continuing

时间：2024-11-28 06:09:23 市场： 美股 综合

关联： ENTO

Entero Therapeutics Announces Proposed Reverse Merger With Journey Therapeutics, a Clinical Stage, First-in-Class, Next-Generation ADC-Rivalling Nano-Immunoconjugates Biopharmaceutical Company

时间：2024-11-13 20:00:03 市场： 美股 综合

关联： ENTO